Insulin or Dapagliflozin Potentially Improves Microcirculatory Dysfunction or <scp>INOCA</scp> Related to Culprit Vessels in Diabetic Patients With <scp>STEMI</scp> After <scp>DCB</scp> Therapy During Long‐Term Follow‐Up
This finding highlights the importance of managing glycemic control, especially using insulin or dapagliflozin, in diabetic patients with STEMI after DCB treatment. Such measures may improve long-term cardiovascular outcomes.
Authors
- Tian Xu (ORCID: https://orcid.org/0000-0001-9278-1622)
- Meili Ji
- Fei Ye
- Yan Xu (ORCID: https://orcid.org/0000-0001-9602-7328)
- Yuxing Wang (ORCID: https://orcid.org/0000-0003-3079-5572)
- Wei You
- Zhiming Wu
- Wenxing Mao
- Xianglian Ma
- Peina Meng
- Tianyi Huang
- Xiangqi Wu
- Xiaoping Jin
- Tianlei Zhang
Institutions
- Nanjing University of Chinese Medicine (CN)
- People's Hospital of Cangzhou (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Journal of Diabetes
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/1753-0407.70197
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 0.00